Eurocine Vaccines expects results from the ongoing immunological analyses in June/July 2017. The samples presently being analyzed were collected during the clinical study on the nasal influenza vaccine candidate Immunose™ FLU, conducted in the current influenza season, 2016/2017.

“I am pleased that the progress of the immunological analyses has been somewhat faster than expected”, said CSO Anna-Karin Maltais.”

Hear Marie Olliver summon the progress of the study in this short video =>

The study can also be followed here www.clinicaltrials.com

Download the Pressrelease here